Indoco Remedies posts Q2 FY25 consolidated loss at Rs. 9.57 Cr
News

Indoco Remedies posts Q2 FY25 consolidated loss at Rs. 9.57 Cr

Indoco Remedies has reported total income of Rs. 434.22 crores during the period ended September 30, 2024

  • By IPP Bureau | October 28, 2024

Indoco Remedies Limited has reported consolidated financial results for the period ended September 30, 2024.

Indoco Remedies has posted net loss of Rs. 9.57 crores for the period ended September 30, 2024 as against net profit of Rs. 2.62 crores for the period ended June 30, 2024. The company posted net profit of Rs. 35.08 crores for the period ended September 30, 2023.

Indoco Remedies has reported total income of Rs. 434.22 crores during the period ended September 30, 2024 as compared to Rs. 432.52 crores during the period ended June 30, 2024. The company reported total income of Rs. 486.16 crores during the period ended September 30, 2023.

For the Half Year ended FY25, Indoco Remedies has reported total income of Rs. 866.74 crores as compared to Rs. 913.07 crores during the 6 months period ended September 30, 2023.

The company has posted net loss of Rs. 6.94 crores for the 6 months period ended September 30, 2024 as against net profit of Rs. 59.46 crores for the 6 months period ended September 30, 2023.

Other Related stories

Startup

Digitization

India is becoming centre of innovation and global execution: Sanjay Vyas, President and MD, Parexel India
India is becoming centre of innovation and global execution: Sanjay Vyas, President and MD, Parexel India
Sanjay Vyas President and Managing Director, Parexel India And Global SBU Head- Safety services & Logistics, Parexel International